Pages that link to "Q42519924"
Jump to navigation
Jump to search
The following pages link to Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients (Q42519924):
Displaying 50 items.
- APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer (Q24304176) (← links)
- Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis (Q26823419) (← links)
- Targeting triple-negative breast cancer: optimising therapeutic outcomes (Q26850892) (← links)
- Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level (Q27300701) (← links)
- A perspective on anti-EGFR therapies targeting triple-negative breast cancer (Q28069867) (← links)
- MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2 (Q28580623) (← links)
- Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. (Q33506542) (← links)
- Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy (Q33609985) (← links)
- Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro. (Q33687560) (← links)
- Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival (Q33699438) (← links)
- FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer. (Q33710341) (← links)
- Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. (Q33856732) (← links)
- Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer (Q34079994) (← links)
- The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer (Q34102670) (← links)
- Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers (Q34162501) (← links)
- Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy (Q34386345) (← links)
- Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer (Q34433737) (← links)
- Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas (Q34438476) (← links)
- A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer (Q34577709) (← links)
- Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups (Q34613569) (← links)
- Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma (Q34748822) (← links)
- A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index (Q35067947) (← links)
- The changing role of pathology in breast cancer diagnosis and treatment (Q35082260) (← links)
- Management Options in Triple-Negative Breast Cancer (Q35155460) (← links)
- Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (Q35237197) (← links)
- Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes. (Q35549438) (← links)
- Triple-Negative Breast Cancer: Clinical and Histological Correlations. (Q35576252) (← links)
- Clinical efficacy of administering oxaliplatin combined with S-1 in the treatment of advanced triple-negative breast cancer (Q35803370) (← links)
- High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature (Q35855332) (← links)
- Triple-negative breast cancer: are we making headway at least? (Q36061177) (← links)
- Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances (Q36157045) (← links)
- Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation (Q36262855) (← links)
- Update on triple-negative breast cancer: prognosis and management strategies (Q36311616) (← links)
- Are triple-negative tumours and basal-like breast cancer synonymous? (Q36465310) (← links)
- Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer (Q36495792) (← links)
- Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer (Q36603829) (← links)
- Development and characterization of two human triple-negative breast cancer cell lines with highly tumorigenic and metastatic capabilities (Q36706840) (← links)
- Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts (Q36746712) (← links)
- Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer (Q36759364) (← links)
- Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines (Q36820542) (← links)
- ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome (Q37003353) (← links)
- Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers. (Q37127021) (← links)
- Immunophenotypic and genomic characterization of papillary carcinomas of the breast (Q37130628) (← links)
- Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection (Q37155717) (← links)
- The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study (Q37232177) (← links)
- Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors (Q37277141) (← links)
- The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer (Q37304764) (← links)
- Basal-like subtype and BRCA1 dysfunction in breast cancers (Q37306567) (← links)
- Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? (Q37356684) (← links)
- Cisplatin and TRAIL enhance breast cancer stem cell death (Q37467572) (← links)